Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Wilson, Amber ^a   Shehadeh, Lina A ^a   Yu, Hong ^a   Webster, Keith A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN 4; LIPOPROTEIN LIPASE; MEMBRANE PROTEIN; PROTEIN ITM2A; PROTEIN P21; PROTEIN P53; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; SIGNAL PEPTIDE;

ADIPOGENESIS; AGING; ANIMAL CELL; ARTICLE; BONE MARROW; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MOUSE; NONHUMAN; ANIMAL; APOPTOSIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; METABOLISM;

MURINAE; MUS;

AGING; ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL CYCLE; CELLS, CULTURED; GENE EXPRESSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL;

EID: 77950645030     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-229     Document Type: Article

References (74)

1. Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Research Reviews 2006, 5:91-116. 10.1016/j.arr.2005.10.001, 16310414.
2. He Q, Wan C, Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 2007, 25:69-77. 10.1634/stemcells.2006-0335, 16973831.
3. da Silvaz Meirelles L, Chagastelles PC, Nardi N. Mesenchymal stem cells reside in virtually all post natal organs and tissues. J Cell Sci 2006, 119:2201-2213.
4. Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192. 10.1634/stemcells.19-3-180, 11359943.
5. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003, 18:696-704. 10.1359/jbmr.2003.18.4.696, 12674330.
6. Farrington-Rock C, Crofts NJ, Doherty MJ, et al. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004, 110:2226-2232. 10.1161/01.CIR.0000144457.55518.E5, 15466630.
7. Doherty MJ, Ashton BA, Walsh S, et al. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998, 13:828-838. 10.1359/jbmr.1998.13.5.828, 9610747.
8. Alliston T, Choy L, Ducy P, et al. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001, 20:2254-2272. 10.1093/emboj/20.9.2254, 125448, 11331591.
9. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci 1997, 94:4080-4085. 10.1073/pnas.94.8.4080, 20571, 9108108.
10. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:390-394.
11. Hou Z, Nguyen Q, Frenkel B, et al. Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci 1999, 96:7294-7299. 10.1073/pnas.96.13.7294, 22079, 10377408.
12. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci 1999, 96:10711-10716. 10.1073/pnas.96.19.10711, 17948, 10485891.
13. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105:369-377. 10.1016/S0092-8674(01)00328-2, 11348593.
14. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6:1229-1234. 10.1038/81326, 11062533.
15. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Nature 2001, 410:701-705. 10.1038/35070587, 11287958.
16. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74. 10.1126/science.276.5309.71, 9082988.
17. Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370. 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C, 10931522.
18. Gao J, Dennis JE, Muzic RF, et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Org 2000, 169:12-20.
19. Lee JH, Kosinski PA, Kemp DM. Contribution of human bone marrow stem cells to individual skeletal myotubes followed by myogenic gene activation. Exp Cell Res 2005, 307(1):174-182. 10.1016/j.yexcr.2005.03.008, 15922737.
20. Mori L, Bellini A, Stacey MA, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005, 304:81-90. 10.1016/j.yexcr.2004.11.011, 15707576.
21. Cao Y, Sun Z, Liao L, et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005, 332:370-379. 10.1016/j.bbrc.2005.04.135, 15896706.
22. Shiota M, Heike T, Haruyama M, et al. Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. Exp Cell Res 2007, 313:1008-1023. 10.1016/j.yexcr.2006.12.017, 17289022.
23. Picinich SC, Mishra PJ, Mishra PJ, et al. The therapeutic potential of mesenchymal stem cells. Cell & tissue-based therapy. Expert Opin Biol Ther 2007, 7:965-973. 10.1517/14712598.7.7.965, 17665987.
24. Nagy RD, Tsai BM, Wang M, et al. Stem cell transplantation as a therapeutic approach to organ failure. J Surg Res 2005, 129:152-160. 10.1016/j.jss.2005.04.016, 16045936.
25. Bang OY, Lee JS, Lee PH, et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005, 57(6):874-882. 10.1002/ana.20501, 15929052.
26. Rubin H. Promise and problems in relating cellular senescence in vitro to aging in vivo. Arch Gerontol Geriatr 2003, 34:275-286.
27. Vacek A. Proliferation activity and number of stromal (CFU-f) and haemopoietic (CFUs) stem cells in bone marrow and spleen of rats of different ages. Acta Vet 2000, 69:25-31.
28. Yue B, Lu B, Dai KR, Zhang XL, Yu CF, Lou JR, Tang TT. BMP2 gene therapy on the repair of bone marrow defect of aged rats. Calcif Tissue Int 2005, 77:395-403. 10.1007/s00223-005-0180-y, 16362458.
29. Stenderup K, Justesen J, Claudsen C. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926. 10.1016/j.bone.2003.07.005, 14678851.
30. Lee CC, Ye F, Tarantal AF. Comparisons of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. Stem Cells Dev 2006, 15:209-220. 10.1089/scd.2006.15.209, 16646667.
31. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, Madon E, Fagioli F. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 2006, 97:744-754. 10.1002/jcb.20681, 16229018.
32. Baxter MA, Wynn RF, Jowitt SN, et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004, 22:675-682. 10.1634/stemcells.22-5-675, 15342932.
33. Liu L, DiGirolamo CM, Navarro PA, Blasco MA, Keefe DL. Telomerase deficiency impairs differentiation of mesenchymal stem cells. Exp Cell Res 2004, 294:1-8. 10.1016/j.yexcr.2003.10.031, 14980495.
34. Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953. 10.1126/science.289.5481.950, 10937998.
35. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000, 113:1161-1166.
36. Moerman EJ, Teng K, Lipschitz DA, et al. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell 2004, 3(6):379-389. 10.1111/j.1474-9728.2004.00127.x, 1850101, 15569355.
37. Zheng H, Martin JA, Duwayri Y, et al. Impact of aging on rat bone marrow-derived stem cell chondrogenesis. J Gerontol A Biol Sci Med Sci 2007, 62(2):136-148.
38. Wall ME, Bernacki SH, Loboa EG. Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal stem cells. Tissue Eng 2007, 13(6):1291-1298. 10.1089/ten.2006.0275, 17518709.
39. Tokalov SV, Grüner S, Schindler S, et al. Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells Dev 2007, 16:439-46. 10.1089/scd.2006.0078, 17610374.
40. Nishida S, Endo N, Yamagiwa H, et al. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab 1999, 17:171-177. 10.1007/s007740050081, 10757676.
41. Chen WT, Shih T, Chen RC, et al. Vertebral bone marrow perfusion evaluated with dynamic contrast-enhanced MR imaging: significance of aging and sex. Radiology 2001, 220:213-218.
42. Schellinger D, Lin CS, Hatipoglu HG, et al. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol 2001, 22:1620-1627.
43. Karagiannides I, Tchkonia T, Dobson DE, et al. Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1772-1780.
44. Meirelles Lda S, Nardi NB. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 2003, 123:702-11. 10.1046/j.1365-2141.2003.04669.x, 14616976.
45. Schadt EE, Edwards SW, GuhaThakurta D, et al. A comprehensive transcript index of the human genome generated using microarrays and computational approaches. Genome Biol 2004, 5:R73. 10.1186/gb-2004-5-10-r73, 545593, 15461792.
46. Dougherty CJ, Kubasiak LA, Frazier DP, et al. Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation. FASEB J 2004, 18:1060-1070. 10.1096/fj.04-1505com, 15226266.
47. Jørgensen NR, Henriksen Z, Sørensen OH, et al. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 2004, 69:219-226. 10.1016/j.steroids.2003.12.005, 15183687.
48. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 3(5):e2213.
49. Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, Baggett LS, Mikos AG, Cao Y. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008, 9(60).
50. Pan Z, Yang J, Guo C, Shi D, Shen D, Zheng Q, Chen R, Xu Y, Xi Y, Wang J. Effects of hindlimb unloading on ex vivo growth and osteogenic/adipogenic potentials of bone marrow-derived mesenchymal stem cells in rats. Stem Cells Dev 2008, 17(4):795-804. Adipo down with passage 2-8, 10.1089/scd.2007.0254, 18710346.
51. Wall ME, Bernacki SH, Loboa EG. Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal stem cells. Tissue Eng 2007, 13(6):1291-8. 10.1089/ten.2006.0275, 17518709.
52. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008, 29(5):258-89. 10.1016/j.mam.2008.08.001, 18762209.
53. Chen CZ, Li M, de Graaf D, Monti S, Göttgens B, Sanchez MJ, Lander ES, Golub TR, Green AR, Lodish HF. Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci USA 2002, 99(24):15468-73. 10.1073/pnas.202614899, 137740, 12438646.
54. Pierelli L, Bonanno G, Rutella S, Marone M, Scambia G, Leone G. CD105 (endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymphoma 2001, 42(6):1195-206. 10.3109/10428190109097744, 11911400.
55. Lu H, Guo L, Wozniak MJ, Kawazoe N, Tateishi T, Zhang X, Chen G. Effect of cell density on adipogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2009, 381(3):322-7. 10.1016/j.bbrc.2009.01.174, 19309772.
56. Zhou H, Mak W, Zheng Y, Dunstan CR, Seibel MJ. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem 2008, 283(4):1936-45. 10.1074/jbc.M702687200, 18045882.
57. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 2002, 71(1):36-44. 10.1007/s00223-001-2059-x, 12200657.
58. Roura S, Farré J, Soler-Botija C, Llach A, Hove-Madsen L, Cairó JJ, Gòdia F, Cinca J, Bayes-Genis A. Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells. Eur J Heart Fail 2006, 8(6):555-63. 10.1016/j.ejheart.2005.11.006, 16507351.
59. Li Y, Jenkins CW, Nichols MA, et al. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994, 9:2261-2268.
60. Edwards MG, Anderson RM, Yuan M, et al. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics 2007, 23:8-80.
61. Sharpless NE, DePinho RA. p53, Good Cop/Bad Cop. Cell 2002, 110:9-12. 10.1016/S0092-8674(02)00818-8, 12150992.
62. Aladjem MI, Spike BT, Rodewald LW, et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 1998, 8:145-155. 10.1016/S0960-9822(98)70061-2, 9443911.
63. Prost S, Bellamy COC, Clarke AR, et al. p53-independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett 1998, 425:499-504. 10.1016/S0014-5793(98)00296-8, 9563521.
64. Park JS, Kim HY, Kim HW, et al. Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech Ageing Dev 2005, 126:551-559. 10.1016/j.mad.2004.11.014, 15811424.
65. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991, 196:33-39. 10.1016/0014-4827(91)90453-2, 1652450.
66. Wei W, Herbig U, Wei S, et al. Loss of retinoblastoma but not p16 function allows bypass of replicative senescence in human fibroblasts. EMBO Rep 2003, 4:1061-1066. 10.1038/sj.embor.7400001, 1326371, 14566323.
67. Hemmings C. The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis. Pathology 2010, 42(2):105-12. 10.3109/00313020903488773, 20085510.
68. Chobotova K. Aging and cancer: converging routes to disease prevention. Integr Cancer Ther 2009, 8(2):115-22.
69. Liu Y, Elf SE, Asai T, Miyata Y, Liu Y, Sashida G, Huang G, Di Giandomenico S, Koff A, Nimer SD. The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle 2009, 8(19):3120-4.
70. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive hematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:750-751. 10.1038/nature04186, 16341000.
71. Schilling T, Küffner R, Klein-Hitpass L, et al. Microarray analyses of transdifferentiated mesenchymal stem cells. J Cell Biochem 2008, 103(2):413-33. 10.1002/jcb.21415, 17610236.
72. Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev 2009, 8(4):339-48. 10.1016/j.arr.2009.06.001, 19576300.
73. Bellantuono I, Aldahmash A, Kassem M. Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochim Biophys Acta 2009, 1792(4):364-70.
74. Flurkey K, Currer JM, Harrison DE. The Mouse in Aging Research. The Mouse in Biomedical Research 2007, 637-672. American College Laboratory Animal Medicine (Elsevier), Burlington, MA, Fox JG, et al, 2.